Griha Hatchell, MS

Pfizer Inc.

Poster(s):

• (C-203) Incorporation of Tokenized Real-World Data into a Phase 4 Vaccine Effectiveness Study: Assessment of Feasibility and Utility
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET